These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 22465936

  • 1. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT, Rao YK, Ye M, Wu WS, Chang TC, Wang LS, Wu CH, Wu AT, Tzeng YM.
    Toxicol Appl Pharmacol; 2012 May 15; 261(1):31-41. PubMed ID: 22465936
    [Abstract] [Full Text] [Related]

  • 2. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q, Yao G, Zhang M, Guo G, Hu Y, Jiang J, Cheng L, Shi J, Li H, Zhang Y, Liu H.
    Carcinogenesis; 2015 Mar 15; 36(3):318-26. PubMed ID: 25600769
    [Abstract] [Full Text] [Related]

  • 3. Destruxin B inhibits hepatocellular carcinoma cell growth through modulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Huynh TT, Rao YK, Lee WH, Chen HA, Le TD, Tzeng DT, Wang LS, Wu AT, Lin YF, Tzeng YM, Yeh CT.
    Toxicol In Vitro; 2014 Jun 15; 28(4):552-61. PubMed ID: 24434019
    [Abstract] [Full Text] [Related]

  • 4. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 15; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 5. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.
    Tian W, Han X, Yan M, Xu Y, Duggineni S, Lin N, Luo G, Li YM, Han X, Huang Z, An J.
    Biochemistry; 2012 Jan 17; 51(2):724-31. PubMed ID: 22224445
    [Abstract] [Full Text] [Related]

  • 6. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.
    Gastroenterology; 2014 Aug 17; 147(2):430-442.e8. PubMed ID: 24846398
    [Abstract] [Full Text] [Related]

  • 7. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD, Sun GB, Jiao P, Chen C, Liu QF, Huang XL, Zhang R, Cai WY, Li SN, Wu JF, Liu YJ, Wu RS, Xie YY, Chan EC, Liou YC, Li BA.
    Gastroenterology; 2016 Mar 17; 150(3):659-671.e16. PubMed ID: 26619963
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
    Lee MA, Park HJ, Chung HJ, Kim WK, Lee SK.
    J Nat Prod; 2013 Jul 26; 76(7):1278-84. PubMed ID: 23855266
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL.
    Oncogene; 2012 May 31; 31(22):2750-60. PubMed ID: 21963845
    [Abstract] [Full Text] [Related]

  • 11. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ, Park HJ, Chung HJ, Min HY, Park EJ, Lee MA, Shin Y, Lee SK.
    Mol Pharmacol; 2012 Aug 31; 82(2):168-77. PubMed ID: 22550094
    [Abstract] [Full Text] [Related]

  • 12. P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth.
    He H, Huynh N, Liu KH, Malcontenti-Wilson C, Zhu J, Christophi C, Shulkes A, Baldwin GS.
    Cancer Lett; 2012 Apr 01; 317(1):65-71. PubMed ID: 22100495
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J, Xie N, Xie K, Zeng J, Cheng L, Lei Y, Liu Y, Song L, Dong D, Chen Y, Zeng R, Nice EC, Huang C, Wei Y.
    Carcinogenesis; 2013 Dec 01; 34(12):2861-9. PubMed ID: 23803691
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
    Wei W, Chua MS, Grepper S, So S.
    Int J Cancer; 2010 May 15; 126(10):2426-36. PubMed ID: 19662654
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.